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To assess whether internalization of /3-adrenergic receptor oc- 
curs in the CNS, we have isolated clathrin-coated vesicles from 
bovine forebrain and examined them for the presence of &ad- 
renergic receptor binding and adenylate cyclase activities. A 
coated vesicle enriched preparation isolated by successive D,O- 
Ficoll density gradient centrifugations was applied to a glass 
bead permeation column to achieve further purification. Two 
major peaks of protein were eluted from the column and moni- 
tored by electron microscopy and SDS-PAGE. Peak II con- 
tained almost exclusively coated vesicles (98%), whereas peak 
I, which appeared in the void volume, contained larger smooth 
vesicles and few coated vesicles. &Adrenergic receptor binding 
to peaks I and II was measured with 1251-cyanopindolol (CYP) 
as ligand in Sepharose 4B column assays. 1251-CYP was found 
to bind specifically and saturably to both peaks I and II with a 
B,,, of 28 f 4 and 32 f 3 fmol/mg protein, respectively. 3H- 
CGP 12177, a hydrophilic /3-adrenergic receptor ligand, did not 
label receptors present in peak II, but it specifically bound to 
synaptic plasma membranes (SPM) prepared from bovine hip- 
pocampus and, to a lesser extent, to peak I. These results sug- 
gest that receptors present in coated vesicles are cryptic in nature. 
In the displacement of 1251-CYP binding by (-)-isoproterenol, 
addition of 50 PM GppNHp caused a significant “right shift” 
with SPM and peak I but not the peak II preparation. Adenyl- 
ate cyclase activities could also be detected in both peaks I and 
II (specific activities, 21 t- 0.6 and 24 f 0.5 pmol cAMP/mg 
protein/min, respectively). These activities were not influenced 
by GTP or GTP plus isoproterenol. Rechromatography of peak 
II on the glass bead column revealed that appreciable amounts 
of protein, CYP binding, and adenylate cyclase activities could 
be recovered in peak I; this change in chromatographic pattern 
was facilitated by pretreatment of coated vesicles with 0.5 M 
Tris, which has been shown to uncoat these vesicles. This sug- 
gests that at least some of the protein, as well as CYP binding 
and cyclase activities, found in peak I originated from coated 
vesicles following loss of clathrin and aggregation. Our results 
support the concept that B-adrenergic receptor and adenylate 
cyclase detected in coated vesicles are molecular entities 
undergoing endocytotic or exocytotic intracellular transport. 
Coated vesicles, originally described by Roth and Porter (1964), 
appear to be present in virtually all eukaryotic cells. One of the 
best defined functions of coated vesicles is that of receptor- 
mediated internalization of specific ligands; it has been shown 
morphologically that they are involved in the uptake of a variety 
of substances, including low-density lipoprotein, yolk protein, 
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transferrin, epidermal, and NGFs, insulin, and immunoglobu- 
lins (reviewed by Fine and Ockleford, 1984; Goldstein et al., 
1979). In this process, coated vesicles appear to bud from coated 
pits in the plasma membrane and then rapidly lose their coating 
to become part of the endosomes or receptosomes before they 
fuse with intracellular organelles such as lysosomes. It has also 
been suggested that coated vesicles are involved in the transport 
of molecules between organelles such as the endoplasmic retic- 
ulum and the Golgi apparatus and between the Golgi and the 
plasma membrane (Bursztan and Fischbach, 1984; Palade and 
Fletcher, 1977; Rothman and Fine, 1980; Rotundo and Fam- 
brough, 1980). Coated vesicles were first purified to near ho- 
mogeneity by Pearse (1976) and shown to contain a major pro- 
tein of 180,000 Da termed clathrin. In addition, 3 prominent 
groups ofpolypeptides have been associated with purified coated 
vesicles isolated from brain and several other tissues. These 
proteins have molecular weights of approximately 1 lO,OOO- 
100,000,55,000-50,000, and 38,000-35,000, respectively(Gar- 
bem and Wu, 198 1; Mello et al., 1980; Pfeffer et al., 1983; Pilch 
et al., 1983; Rothman and Fine, 1980; Wood et al., 1978). 
Isolated coated vesicles have been shown to contain molecules 
such as transferrin, ferritin, and immunoglobulin (Pearse, 1982) 
and receptors for low-density lipoprotein (Mello et al., 1980), 
insulin (Pilch et al., 1983), ACh (Porter-Jordan et al., 1982), 
and opioids (Bennett et al., 1985). 
Evidence has accumulated suggesting that P-adrenergic re- 
ceptor binding sites may be internalized during agonist-induced 
receptor down-regulation in frog erythrocytes (Chuang and Cos- 
ta, 1979; Stadel et al., 1983) and several cultured cell systems 
(Harden et al., 1980; Mahan et al., 1985; Pittman and Molinoff, 
1980; Staehelin and Hertel, 1982). In the CNS, P-adrenergic 
receptors can be down-regulated by pharmacological manipu- 
lations. For example, chronic treatment of experimental animals 
with various antidepressant drugs is known to cause a loss of 
P-adrenergic receptors in the brain, and this receptor down- 
regulation is generally believed to be relevant to the therapeutic 
action of these drugs (reviewed by Chuang and Costa, 1984). 
However, little is known as to whether P-receptor internalization 
occurs in the CNS. We reasoned that if /3-adrenergic receptors 
in the CNS are internalized by mechanisms involving coated 
pits, isolated coated vesicles should contain these binding sites. 
In this report we present evidence for the association of p-ad- 
renergic receptors with purified coated vesicles and show that 
the characteristics of these receptors differ in some respects from 
those found in synaptic plasma membranes (SPM). 
Materials and Methods 
Isolation of coated vesicles 
Coated vesicles were isolated from bovine forebrain (freshly obtained 
from a local slaughterhouse) using the procedures of Pfeffer and Kelly 
(1985). Briefly, 2 brains (about 600 gm) were dissected to remove the 
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meninges and homogenized in an equal volume of homogenization 
buffer (see below). The crude microsomal (100,000 x g) pellet obtained 
from 20,000 x g supematant was subjected to 3 successive continuous 
D,O-Ficoll gradient centrifugations (9% D,O-2% Ficoll to 90% D,O- 
20% Ficoll). The resulting coated vesicle-enriched preparation (60-80%) 
was applied to a controlled pore glass bead permeation column (1.5 x 
110 cm; mean pore diameter, 205 nm) to achieve further purification. 
Two protein peaks were eluted from the column and were monitored 
by electron microscopy and SDS-PAGE (see Results). Materials present 
in peak II of the column are referred to as coated vesicles. Peaks I and 
II obtained from the column were frozen immediately at -70°C until 
use. The yields of protein in peaks I and II were about 300 and 700 rg/ 
100 g of brain, respectively. 
Binding of p-adrenergic receptor ligands to peaks I and 
II and synaptic plasma membranes 
Assay mixtures in a final volume of 0.5 ml contained 25 mM Tris HCl 
buffer, pH 7.4, 1 mM MgCl, and indicated concentrations of membrane 
proteins and either 12SI-dl-cyanopindolo1 (CUP, 2200 Ci/mmol; New 
England Nuclear, Boston, MA) or 3H-CGP 12 177 (38 Ci/mmol; Amer- 
sham, Arlington Heights, IL). The binding reaction was terminated after 
incubation at 30°C for 45 min; at this time, the specific binding of both 
ligands had attained an equilibrium. For the binding to peak I or II, the 
reaction mixture was immediately applied to a Sepharose CL 4B (Phar- 
macia, Piscataway, NJ) column (0.6 x 13 cm) that had been equilibrated 
with the above Tris MgCl, buffer at 4°C. The eluate appearing at the 
void volume, which contained radioligand bound to sites in peak I or 
II, was collected for the determination of radioactivity in a y- or p-coun- 
ter for lz51 and 3H, respectively. Details ofthese experimental procedures 
are as described previously (Chuang and Costa, 1979; Chuang et al., 
198 1). Nonspecific binding was measured in the presence of 2 PM un- 
labeled alprenolol and was subtracted from the total binding to obtain 
specific binding (70-90% of the total binding). For the measurement of 
P-receptor binding to sites in peaks I and II, the column assay was found 
to be far more consistent and to produce a higher degree of specific 
binding than the method of filtration through glass fiber filter. Because 
of the size heterogeneity of membrane fragments present in the SPM 
preparation, binding of P-receptor ligands to SPM was measured using 
the conventional glass fiber filtration method. 
Adenylate cyclase assays 
Adenylate cyclase activities present in SPM and peaks I and II were 
assayed in 100 rl of reaction mixture containing 25 mM Tris HCl buffer, 
pH 7.4, 10 mM M&l,, 1 mM EDTA, 0.1 mM ATP, 2 mM phospho- 
creatine, 16 units/ml creatine phosphokinase, 0.5 mM isobutylmethyl- 
xanthine, indicated amounts of protein from SPM and peaks I or II, 
and, when indicated, 10m4 M GTP ? 2 x 10m4 M (-)-isoproterenol hy- 
drochloride. After incubation at 37°C for 15 min. the reaction was 
terminated by addition of 40 ~1 of 0.33 M ZnSO, and 40 ~1 of 0.5 M 
Na,CO, followed by centrifugation to remove the precipitate. An aliquot 
of 100 pl of the supematant was subjected to acetylation and the acetylat- 
ed CAMP content was determined by radioimmunoassay using rabbit 
antibodies raised against 2’-O-succinyl-CAMP as reported (Harper and 
Brooker, 1975). The amounts of CAMP present in SPM, and peak I or 
II at incubation time zero were considered as the background and sub- 
tracted, these values were less than 0.4 pmol/mg protein. The reaction 
was linear up to 20 min when incubated at 37°C. 
Procedures for the treatment of coated vesicles with 0.5 M Tris 
About 5 mg protein obtained from peak II of the controlled glass bead 
permeation column was diluted with an equal volume of homogeni- 
zation buffer (10 mM HEPES, pH 7.4, 0.1 mM MgCl,, 150 mM NaCl, 
1 mM EGTA) and centrifuaed at 100.000 x P for 1 hr. Half of the 
resulting pellets were resuspended in 5 ml of homogenization buffer, 
and the remainder was added to the same volume of homogenization 
buffer containing 0.5 M Tris HCl, pH 7.4. After incubation at room 
temperature for 30 mitt, these mixtures were centrifuged at 150,000 x 
,e for 1 hr. The supematants were collected for protein analysis, and the 
pellets were individually resuspended in a small volume of the column 
buffer (10 mM HEPES. DH 7.0. 200 mM sucrose. 300 mM NaCl. 10 mM 
EGTA) and rechromatbgraphed on 2 glass bead permeation columns 
run in parallel. Peaks I and II derived from Tris-treated and control 
coated vesicles were centrifuged at 200,000 x g for 4 hr and the pellets 
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Figure 1. Chromatography of a coated vesicle-enriched preparation 
from a controlled pore glass bead column. Coated vesicles (about 8-10 
pg protein) purified through 3 successive cycles of D,G-Ficoll density 
gradient centrifugations were chromatographed onto a glass bead col- 
umn and eluted with the column buffer (see Materials and Methods). 
The flow rate was 6 ml/hr. Fractions as shown were pooled to form 
preparations of peaks I and II. Peak I corresponded to the void volume 
of the column. 
determination, adenylate cyclase assay, and @-adrenergic receptor bind- 
ing activity measurement. 
Electron microscopy 
Samples of peaks I and II derived from the glass bead column were 
resuspended in a fixative solution containing 1% paraformaldehyde and 
1% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4, and placed in 
the cold for 1 hr. The fixed material was rinsed in sodium cacodylate, 
postfixed in 1% 0~0, for 1 hr, and dehydrated in a series of graded 
ethanols and propylene oxide. Final embedding was carried out in Epox- 
Araldite (Fullam). Thin sections were cut with a diamond knife on a 
LKB III Ultramicrotome and. after stainina with uranvl acetate and 
lead citrate, viewed with a JELL 1OOCX EM. 
Other methods 
SPM were prepared from bovine hippocampal-dentate gyrus as de- 
scribed (Roth et al., 1982) and resuspended in the above column buffer 
before use. Protein was determined using the method of Lowry et al. 
(1951). 
Results 
Characterization of coated vesicles isolated from bovine brain 
Since it had been reported that the high osmolarity of conven- 
tional sucrose gradient centrifugation results in loss of coated 
vesicle content (Nandi et al., 1983), D,O-Ficoll equilibrium 
gradients (Pfeffer and Kelly, 1985) were used to isolate coated 
vesicles from bovine brain. The resulting coated vesicle-en- 
riched preparation was chromatographed onto a controlled pore 
glass bead column (Pfeffer et al., 1983) to achieve further pu- 
rification. As Figure 1 shows, 2 major A,,, nm absorbing peaks 
with little overlap were eluted from the column. These 2 peaks 
were characterized by electron microscopy and SDS-PAGE. Peak 
II contained almost exclusively (up to 98%) coated vesicles and 
some empty baskets. Coated vesicle dimensions varied from 40 
to 120 nm, with a mean value of about 60 nm (Fig. 2B). In 
contrast, peak I, which appeared in the void volume of the 
column, consisted predominantly of larger smooth vesicles, al- 
though a few coated vesicles and some filamentous structures 
were also found (Fig. 2A). Analysis by SDS-PAGE confirmed 
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Figure 2. Electron micrographs of peaks I and II eluted from the glass bead column. A, The glass bead column-excluded materials (peak I) 
containing mostly smooth vesicles and membrane fragments. Coated vesicles were extremely rare in this fraction. B, Coated vesicle-enriched 
fraction that was retained on the column (peak II) containing almost exclusively coated vesicles and baskets with no apparent central vesicle. 
Occasional uncoated vesicles were seen. x 99,000. 
that the major protein in coated vesicles (peak II) is the clathrin 
heavy chain of approximately 180,000 Da (Fig. 3). In addition, 
3 protein doublets were detected with molecular weights of 
1 lO,OOO-100,000, 55,000-50,000, and 38,00&35,000. Peak I 
consisted mainly of a protein with 55,000 Da and a relatively 
small quantity of the 180,000 Da clathrin heavy chain. 
P-Adrenergic receptor binding activity 
To assess the presence of &adrenergic receptor binding sites in 
peaks I and II, we used L251-CYP as ligand and Sepharose CL 
4B column chromatography to separate free CYP from CYP 
bound to supramacromolecular structures. As shown in Figure 
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+ GTP and 
Fractions -GTP +GTP isoproterenol 
Before column (n = 5) 16.3 f 0.4 19.7 + 0.8 22.3 + 1.2 
Peak 1 (n = 6) 21.1 f 0.6 23.5 f 1.1 24.0 + 0.8 
Peak 11 (n = 6) 24.2 k 0.5 25.7 t 0.6 25.0 f 0.7 
SPM (n = 3) 111.2 & 4.1 156.0 + 6.2 199.0 & 7.4 
Conditions of adenylate assay are described in Materials and Methods. The amounts 
of protein used per assay were 6-18 @ for all fractions. These protein concentrations 
were all in the linear range of activity. 
4A, 1251-CYP was specifically bound to sites in peaks I and II 
in a saturable manner, as it was to SPM. The B,,, values cal- 
culated by Scatchard analyses from 4 separate experiments were 
28 + 4 and 32 f 3 fmol/mg protein for peaks I and II, respec- 
tively, and 172 f 18 fmol/mg protein for SPM (data not shown). 
It is seen in Figure 4B that 3H-CGP 12 177, a hydrophilic ligand 
for /3-adrenergic receptors (Staehelin and Hertel, 1982), failed 
to label receptors present in peak’11 but was specifically bound 
to SPM and, to a much lesser extent, to peak I. These results 
suggest that @-adrenergic receptors present in coated vesicles are 
cryptic in nature. 
The binding of 1251-CYP to peaks I as well as II and SPM was 
displaced effectively by (-)-alprenolol (IC,, - 5 x 1O-9 M) and 
relatively weakly by (-)-isoproterenol (IC,, = 2 to 8 x 1O-6 M) 
(Fig. 5). (+)-Isoproterenol, the stereoisomer, failed to affect this 
binding at 1O-6 M (data not shown). The addition of 50 PM 
GppNHp was without effect on the displacement by (-)-iso- 
proterenol of 1251-CYP binding to peak II (Fig. 5B), whereas a 
significant “right shift” (about 4-fold increase in IC,,) and an 
increase in the steepness of the displacement curve was found 
when SPM was used (Fig. 5C). A similar but smaller effect of 
GppNHp on the isoproterenol displacement curve was seen in 
the binding of 1251-CYP to peak I (Fig. 5A). In all 3 preparations, 
the Hill coefficients were approaching 1 (> 0.88) when isoprote- 
renol displacements were performed in the presence of GppNHp. 
The presence of GppNHp did not change the displacement be- 
havior of alprenolol in any of the 3 preparations (Fig. 5). 
Activities of adenylate cyclase 
Since adenylate cyclase is a component of the /I-adrenergic re- 
ceptor complex, we attempted to detect it in peaks I and II, the 
coated vesicle enriched before column preparation, and SPM. 
These results are summarized in Table 1. Adenylate cyclase 
activities were found in both peaks I and II with specific activ- 
ities of 21 f 0.6 and 24 ? 0.5 pmol cAMP/mg protein/min, 
respectively. These activities were unchanged by the addition 
of GTP (1O-4 M) f isoproterenol(2 x 1O-4 M). In contrast, the 
cyclase activity in the SPM was significantly stimulated by GTP 
alone (40% increase) and in the presence of isoproterenol(80% 
increase). Cyclase activities present in peaks I and II were not 
significantly stimulated by 10 mM NaF. These activities were 
dependent on incubation temperature; an incubation at 4°C failed 
to increase CAMP content. Boiling peaks I and II preparations 
for 3 min completely abolished their adenylate cyclase activity. 
Efect of Tris treatment on the chromatographic 
pattern of coated vesicles 
Since specific activities of p-adrenergic receptor binding and 
adenylate cyclase detected in peak I were almost equal to those 
found in peak II, we investigated the possibility that these peak 
I-associated activities might be derived from coated vesicles in 
peak II. Keen et al. (1979) first reported that treatment of coated 










Figure 3. SDS-PAGE of peaks 1 and 11 materials. Peak I(1 5 I.cg protein) 
and peak ll(l20 pg protein) fractions were subjected to 10% PAGE in 
the presence of SDS as described (Laemmli, 1970). In order to detect 
minor protein components associated with the coated vesicle prepa- 
ration, a greater amount of peak 11 was loaded onto the gel. Coomassie 
blue-stained proteins are shown together with positions of the following 
protein standards: myosin (205K), &galactosidase (116K), phosphory- 
lase B (92.5K), BSA (66K), ovalbumin (45K), carbonic anhydrase (3 1 K), 
and soybean trypsin inhibitor (21K). 
Table 2. Protein content, adeuylate cyclase activity and p-adrenergic 
receptor binding in control and Tris-treated coated vesicles 
Tris-treated 
Peak 1 Peak 11 
Control 
Peak 1 Peak 11 
Protein content 182 112 113 154 
(KS) (165%) (100%) (73%) (100%) 
1251-CYP binding 9.34 5.77 4.88 7.86 
(fmol bound) (161%) (100%) (62%) (100%) 
Adenylate cyclase 5.62 2.85 2.83 4.01 
(pmol cAMP/min) (190%) (100%) (70%) (100%) 
Conditions of the treatment of coated vesicles with 0.5 M Tris and the reisolation 
of peaks I and II from glass bead columns are described in Materials and Methods. 
Aliquots of peaks I and II were assayed for protein content, ‘251-CYP binding, and 
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Figure 4. Binding of V-CYP (A) and ‘H-CGP 12177 (B) to peaks I and II and synaptic plasma membranes. Procedures of the binding are as 
described in Materials and Methods. The amounts of protein used per assay were 36, 49, and 26 fig for peaks I and II and SPM, respectively. 
These protein concentrations were in the linear range of activity. Nonspecific binding was determined in the presence of 2 PM (-)-alprenolol and 
subtracted from the total binding to obtain the specific binding. The specific activities of 12sI-CYP and ‘H-CGP 12 177 were 28 10 and 60 cpm/ 
fmol, respectively. The data presented are from 1 experiment that was reproduced 4 times. For the sake of accuracy in illustrating the number of 
binding sites, the Y-scales for vesicular fractions (peaks I and II) and for the SPM, are not the same. 
vesicles with 0.5 M Tris HCl removes clathrin and a 110,000 
Da polypeptide from coated vesicles. We adopted these exper- 
imental conditions to examine whether this decoating process 
alters the chromatographic patterns of adenylate cyclase and 
@-adrenergic receptors originally associated with coated vesicles. 
Thus, the peak II preparation obtained from the glass bead 
column was pelleted by centrifugation, divided into 2 portions 
and resuspended, one was exposed to 0.5 M Tris and the other 
was used as control. After Tris treatment, these materials were 
again centrifuged and the pellets were resuspended and rechro- 
matographed on glass bead columns. As seen in Figure 6, Tris 
treatment drastically changed the elution pattern of coated ves- 
icles with the majority of the proteins originally associated with 
peak II appearing in peak I (Fig. 6A). In the control sample, an 
appreciable amount (about 30% of the total) of coated vesicle- 
associated protein could also be recovered in peak I upon re- 
chromatography (Fig. 6B). 
SDS-PAGE analysis of the Tris extract of coated vesicles 
(recovered in the 150,000 x g supernatant) revealed that Tris 
treatment removed at least 5 times more clathrin heavy and 
light chains and a 110,000 Da polypeptide than control (results 
not shown). Materials in peaks I and II of T&treated and 
control samples were reisolated by centrifugation and then as- 
sayed for protein content and activities of P-receptor binding 
and adenylate cyclase. The data in Table 2 show that 1251-CYP 
binding and adenylate cyclase activities were shifted in parallel 
with protein contents from peak II to peak I from both Tris- 
treated and control samples. 
Discussion 
In the present study, we presented evidence for the occurrence 
of ,&adrenergic receptor binding sites in a coated vesicle prep- 
aration obtained from bovine brain. Coated vesicles were iso- 
lated by D,O-Ficoll gradient centrifugation to preserve the in- 
tegrity of structures and by glass bead column chromatography 
to remove uncoated materials. The purity of coated vesicles was 
verified by electron microscopy and SDS-PAGE (Figs. 2, 3). 
1251~CYP binding to /3-adrenergic receptors in the purified coated 
vesicle preparation was displaced potently by (-)-alprenolol and 
relatively weakly by isoproterenol in a stereospecific manner, 
as was binding to SPM (Fig. 5). However, the characteristics of 
/Ladrenergic receptor binding associated with the peak II prep- 
aration differ from those of SPM in 2 regards: (1) The displace- 
ment of CYP binding by (-)-isoproterenol was unaffected by 
the addition of guanine nucleotides and contrasted with the 
“right shift” observed with SPM (Fig. 5); and (2) 3H-CGP 12 177, 
a hydrophilic ligand that labels only cell-surface receptors be- 
cause of its inability to traverse membrane, bound to receptors 
in SPM but not with those in the coated vesicle preparation 
(Fig. 4), suggesting the presence of “latent” receptors in coated 
vesicles. Latency of receptors for low-density lipoprotein and 
insulin has also been shown in isolated coated vesicles (Mello 
et al., 1980; Pilch et al., 1983). In these studies, latent receptors 
were unmasked by pretreatment of coated vesicles with octyl- 
glucoside. Since we found that octyl-glucoside severely damages 
,B-adrenergic receptors present in coated vesicles and other prep- 
arations, we were unable to use this detergent to unmask re- 
ceptors in our study. It is interesting to note that the binding 
characteristics of the coated vesicle preparation-i.e., the po- 
tency of (-)-isoproterenol for binding displacement, the slope 
of the displacement curve, and the lack of effect of guanine 
nucleotide on the isoproterenol binding-are similar to those 
found in “internalized” @-adrenergic receptors present in vas- 
cular structures derived from frog erythrocytes desensitized with 
@-adrenergic agonists (Chuang et al., 198 1; Stadel et al., 1983). 
It should, however, be noted that a 6-fold lower density of Iz51- 
CYP binding sites was found in coated vesicles than in the 
plasma membranes (Fig. 4), suggesting that only a small fraction 
of coated vesicles are involved in b-receptor transport. These 
results are not surprising because this purified population of 
coated vesicles is extremely heterogenous; they may arise from 
various types of neurons and several classes of glial cells. 
Adenylate cyclase activity was also detected in the coated 
vesicle preparation. Furthermore, this cyclase activity was un- 
changed by the addition of GTP or GTP plus isoproterenol, 
whereas these agents elicited a significant activation of the ac- 
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tivity in SPM (Table 1). These results support the notion that 
the adenylate cyclase present in coated vesicles is uncoupled 
from the guanine nucleotide binding protein (Ns) and the & 
receptor binding site, thus arguing against the possibility that 
activities of cyclase and receptor binding are due to insertion 
into or contamination of coated vesicles with fragments of plas- 
ma membranes during the isolation procedure. To our knowl- 
edge, these results represent the first time that this enzyme has 
been localized in brain coated vesicles, and they differ from 
those reported by Hadjiivanova et al. (1984) who suggested an 
entirely plasma membrane origin of adenylate cyclase in the 
liver. 
The properties of p-receptor binding site and adenylate cyclase 
present in the peak I preparation are reminiscent of those found 
in the peak II; however, their precise origin requires further 
investigation. Electron micrographs show that the peak I prep- 
aration was heterogenous, containing mainly smooth vesicles, 
some filamentous structures and a few coated vesicles (Fig. 2). 
It is generally agreed that the clathrin coats are lost very rapidly 
Figure 5. Effects of GppNHp on the 
displacement by (-)-isoproterenol and 
(-)-alprenolol of ‘751-CYP binding to 
peak I (A), peak II (B), and synaptic 
plasma membranes (C). Procedures 
ofthebindingareasdescribedinMa- 
terials and Methods. The concentra- 
tion of ‘251-CYP was 200 PM and 
amounts ofproteins used were 30,25, 
and 15 pg for peaks I and II and SPM, 
respectively. When used, the concen- 
tration of GppNHp was 50 PM. lzsI- 
CYP binding that was not displaced 
by 2 x 1O-6 M (-)-alprenolol or 2 x 
10 --4 M (-)-isoproterenol was consid- 
ered as nonspecific binding and sub- 
tracted from the total binding. The 
100% values of the specific binding 
were 16, 18, and 105 fmol/mg protein 
for peaks I and II and SPM, respec- 
tively. The specific activity of 1*51-CYP 
was 2613 cpm/fmol. The data pre- 
sented are from 1 experiment that was 
reproduced 3 times. 
from coated vesicles in vivo, probably within a minute after 
coated vesicle formation (Pearse and Bretscher, 1981). More- 
over, an ATP-dependent uncoating enzyme that has been puri- 
fied appears to form a stoichiometric complex with the clathrin 
trimer (Schmid et al., 1984). Thus, one may speculate that the 
molecular entities of cyclase and receptor detected in peak I may 
be located in smooth vesicles that are derived from coated ves- 
icles by removal of clathrin and aggregation. The results of 
experiments presented in Figure 6 and Table 2 may support this 
view. When peak II material was rechromatographed onto a 
glass bead column, considerable amounts of protein, P-receptor 
binding, and cyclase activities were recovered in peak I. Pre- 
treatment of peak II with 0.5 M Tris, which facilitated the re- 
moval ofclathrin from coated vesicles, resulted in a pronounced 
shift in the absorbance profile and the transfer of binding and 
cyclase activities from peak II to I. 
The size of coated vesicles used in this study varied from 
about 40 to 120 nm. In certain tissues, e.g., liver and adrenal 
cortex, large coated vesicles (90-l 20 nm) are derived from plas- 
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Figure 6. Rechromatography of coated vesicles from controlled pore 
glass bead columns. Coated vesicles from a peak II preparation were 
pelleted by centrifugation and then resuspended in the homogenization 
buffer with (A) or without (B) 0.5 M Tris HCl, pH 7.4. After incubation 
at room temperature for 30 min, the 2 preparations were centrifuged 
and pellets were resuspended and rechromatographed onto 2 glass col- 
umns run in parallel. The 280 nm absorbance of the column eluant was 
recorded. Details of the experimental procedures are as described in 
Materials and Methods. 
ma membranes and involved in receptor-mediated endocytosis, 
whereas small coated vesicles (50-80 nm) are probably of Golgi 
origin and participate in intracellular transport and receptor 
recycling (Goldstein et al., 1979; Pearse and Bretscher, 1981). 
At present, it is unclear whether we can associate the size of 
coated vesicles in the brain with their origin in plasma mem- 
brane or Golgi apparatus. Nor do we know whether large or 
small coated vesicles contain p-receptor and/or adenylate cy- 
clase. Further studies using a morphological approach will be 
essential to identify the origin of these molecular entities and 
to aid our understanding of whether these entities are involved 
in endocytosis or exocytotic intracellular transport. 
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